Invesco Ltd. Vista Gen Therapeutics, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.12 - $0.3 $1,081 - $2,703	9,011 Added 13.31%	76,721 $9,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $55 - $1,905	397 Added 0.59%	67,710 $10,000
Q2 2022 Aug 15, 2022	BUY	$0.88 - $1.73 $1,457 - $2,864	1,656 Added 2.52%	67,313 $59,000
Q1 2022 May 16, 2022	BUY	$1.14 - $2.09 $810 - $1,485	711 Added 1.09%	65,657 $81,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $80,271 - $132,664	-48,067 Reduced 42.53%	64,946 $127,000
Q3 2021 Nov 15, 2021	BUY	$2.62 - $3.45 $71,898 - $94,674	27,442 Added 32.07%	113,013 $309,000
Q2 2021 Aug 17, 2021	BUY	$1.96 - $3.15 $167,719 - $269,548	85,571 New	85,571 $270,000

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $534M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.